Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Reliefband Technologies Unveils The Reliefband Neurowave™ - The Most Advanced Wearable For The Drug-Free Treatment Of Nausea

Designed for everyday use, The Reliefband Neurowave™ combines contemporary design and life changing FDA-cleared technology to help people deeply impacted by nausea regain control of their lives


News provided by

Reliefband Technologies

Jan 03, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

LAS VEGAS, Jan. 3, 2017 /PRNewswire/ -- At CES, Reliefband Technologies, a leader in therapeutic technology has unveiled The Reliefband Neurowave™, the world's most advanced "Treatable" - a wearable device for the drug-free relief from nausea, retching and vomiting caused by morning sickness and motion sickness, including the motion sickness associated with VR SIM.  

Featuring clinically proven, FDA-cleared technology, The Reliefband Neurowave is designed to suit the needs of people whose lives are deeply impacted by nausea. This powerful device allows them to travel without fear of sickness and once again enjoy common leisure pursuits such as cruising, fishing, amusement rides or staying in the VR game. It will be commercially available in early Q2 priced around $150.

The Reliefband Neurowave uses Reliefband Technologies' patented technology that applies accurately programmed pulses with highly specific waveforms, frequency and intensity to modulate the median nerve on the underside of the wrist. This precise activity (technically referred to as "neuromodulation") uses the body's natural neural pathways to block the waves of nausea produced by the stomach. 

The Reliefband Neurowave provides life-changing results for millions who suffer from nausea. It has been designed to be smarter and more comfortable. With both enhanced aesthetics and intuitive controls, this device is ideal for both occasional and all day use. While it leverages the same clinically proven neuromodulation technology as its predecessor Reliefband®, The Reliefband Neurowave has been reengineered to apply this technology in a more efficient and user-friendly way.  Pairing the beauty of a contemporary design, with the fundamentals of FDA-cleared, clinically proven technology, The Reliefband Neurowave offers a range of advanced features including:

  • Unique "J-shaped smart band" makes the device easier to put on and more comfortable to wear over extended periods
  • Innovative band architecture helps secure the contacts more accurately over the median nerve, to minimize user error
  • Stunning aspirational design that rivals the most fashionable wearables makes The Reliefband Neurowave wearable in any active or social setting 
  • New hypoallergenic 316L Surgical Steel contacts, ensure more efficient transmission of current while maximizing user comfort
  • The Reliefband Neurowave contains an intuitive display with 10 intensity settings that can be moved up and down at a touch of a button. This range of settings allow users to find the precise setting that's optimal for their individual needs
  • A fully rechargeable battery

The technology behind The Reliefband Neurowave is clinically proven and FDA-cleared. This technology has been prescribed for nearly 20 years by doctors for the treatment of morning sickness, post-operative nausea and sickness caused by therapies such as chemotherapy. The signals generated by the device travel through the body's central nervous system and the higher emetic center of the brain.1 The signals modulate the neural pathways between the brain and the stomach, via the Vagus nerve, restoring normal gastric rhythm that relieves nausea.2,3

"For the 60 million Americans who frequently suffer with motion sickness and the nearly 80% of women who experience morning sickness during pregnancy, The Reliefband Neurowave is simply life-changing," said Nick Spring, CEO, Reliefband Technologies. "The Reliefband Neurowave was developed in response to customers who told us they had given up hope of controlling their nausea. Their lives are greatly impacted by this motion sickness. They avoid any activity or situation that brings on symptoms. We wanted to help those who are sick of feeling sick by making a drug-free device that is easy-to-use and elegant to wear over long periods. This way they can start living their lives without the worry, embarrassment, discomfort and inconvenience nausea can bring." 

The Reliefband Neurowave provides a drug-free solution that does not have any of the safety concerns or side effects of medications. Such concerns include drowsiness, dry mouth or potential for adverse drug interactions. This is one of the reasons many women silently suffer with morning sickness as they are reluctant to use drugs that can affect the developing baby.  Users need only slip the device onto their wrists, adjust the intensity to suit their individual needs and within minutes are feeling better.   

Studies have shown 10% of the population are genetically predisposed to be highly susceptible to motion sickness, which could see at least 18,000 people affected at CES.  Many of those that suffer from motion sickness fall into two categories. Highly susceptible sufferers who avoid travel and miss out on work opportunities, social functions and vacations, and those that battle nausea to partake in activities they love such as sailing, fishing, pleasure flying and even VR gaming. The Reliefband Neurowave puts people back in control of their lives without drugs and without delay.

For more information visit www.reliefband.com

About Reliefband Technologies 
Reliefband Technologies LLC is a neurotechnology company that provides leading edge personalized medical treatments, which put people in control of their treatment and their lives. Reliefband wearable technology products are worn on the wrist and are indicated for the treatment of nausea and vomiting.

Reliefband Technologies was established in 2015 and is headquartered in Horsham, PA.  

1. Yoo SS, Teh EK, Blinder RA, et al. NeuroImage. 2004; 22: 932-940.
2. Koch KM. Dig Dis & Sci. 1990;44(8):53S-7S.
3. Hu S, Stern RM, Koch KL, et al. Gastroenterology. 1992; 102(8):1855-58.

Reliefband Media Contacts:
Sheree N. Johnson / Tandem Marketing Communications
[email protected]      
(917) 783-7349

SOURCE Reliefband Technologies

Related Links

http://www.reliefband.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.